BRIEF-EMA Says Investigation Of AstraZeneca's COVID-19 Vaccine And Thromboembolic Events Continues

March 16 (Reuters) -

• EMA SAYS INVESTIGATION OF COVID-19 VACCINE ASTRAZENECA AND THROMBOEMBOLIC EVENTS CONTINUES

• EMA SAYS EVALUATION IS LOOKING AT AVAILABLE DATA RELATED TO ALL THROMBOEMBOLIC EVENTS REPORTED AFTER ASTRAZENECA COVID-19 VACCINATION

• EMA SAYS NATIONAL AGENCIES ARE PROVIDING ADDITIONAL SUPPORT TO GATHER MISSING AND INCOMPLETE INFORMATION AS QUICKLY AS POSSIBLE

• EMA- EMA'S SAFETY COMMITTEE WILL CONCLUDE ON INFORMATION AVAILABLE AT ITS MEETING ON 18 MARCH &ISSUE ANY NECESSARY RECOMMENDATIONS FOR FURTHER ACTION

• EMA SAYS RAPID AND THOROUGH ANALYSIS OF THE AVAILABLE DATA AND CLINICAL CIRCUMSTANCES SURROUNDING SPECIFIC CASES IS CONTINUING

Source text : https://bit.ly/38LIjP5

Further company coverage: AZN.L

((Reuters.Briefs@thomsonreuters.com;))